register for a free guide

Subscribe via email today


3
Mar

s-HYDROXYCUT-large

NEW YORK (Reuters Health, American Journal of Gastroenterology, January 26, 2010)
The US Food and Drug Administration issued a warning to stop using Hydroxycut, a popular slimming pill manufactured by Canada-based Iovate Health Sciences, based from the reports of serious liver damage and death. The particular study was conducted by researchers of the American Journal of Gastroentorology, which out of 23 patients, 17 were found to suffer adverse symptoms, nine cases were reported to the FDA while eight were witnessed by the research authors themselves. Out of the nine reported, three required liver transplants, and one dead from liver failure.

The Canada-based manufacturer recalled the 14 Hydroxycut products, after having been informed of the FDA assessments of the 23 reports of liver damage, and that the recall was agreed to an “abundance of caution” – given the fact that the 23 reports were only a small percentage out of the millions who have used the product for more than 7 years.

This was examine closely by In the new study, reported in the American Journal of Gastroenterology, researchers analyzed 17 cases of liver damage among Hydroxycut users that had not yet appeared in the medical literature. Nine of the cases had been reported to the FDA, while eight were seen by the authors of the study.

For the total of the 17 cases, three required a liver transplant while one died out of liver failure.

These patients were otherwise healthy before taking Hydroxycut. Symptoms (jaundice, yellowing of the skin, nausea, abdominal pain, vomiting and fatigue) were reported to show up after having taken the said pill.

Though the direct culprit has not been definitely ruled out, public health researcher Ano Lobb who studied Hydroxycut said that the problem ingredient might have been the hydroxycitric acid. It has been linked to liver problems in a medical journal study as other supplements may be present in other supplements as well.

These reports now serve as a clear warning to the public to research any adverse effects a slimming pill might have, before taking them in. The FDA is not empowered to screen supplements first before market release, and can only recommend a recall after side effects are reported.

Category : News

Write a Review of Hydroxycut Recalled After Having Been Linked To Liver Damage